Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting

Subjects: chemotherapy; MASCC–ESMO Clinical Practice Guideline; nausea and vomiting

  • Source: Herrstedt, J, Clark-Snow, R, Ruhlmann, C H, Molassiotis, A, Olver, I, Rapoport, B L, Aapro, M, Dennis, K, Hesketh, P J, Navari, R M, Schwartzberg, L, Affronti, M L, Garcia-Del-Barrio, M A, Chan, A,

Record details

×
Academic Journal

2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting

Subjects: chemotherapy; MASCC–ESMO Clinical Practice Guideline; nausea and vomiting

  • Source: Herrstedt, J, Clark-Snow, R, Ruhlmann, C H, Molassiotis, A, Olver, I, Rapoport, B L, Aapro, M, Dennis, K, Hesketh, P J, Navari, R M, Schwartzberg, L, Affronti, M L, Garcia-Del-Barrio, M A, Chan, A,

Record details

×
Academic Journal

2023 Updated MASCC/ESMO Consensus Recommendations:prevention of radiotherapy- and chemoradiotherapy-induced nausea and vomiting

Subjects: Antiemetic; Concomitant chemotherapy; Guideline

  • Source: Ruhlmann, C H, Jordan, K, Jahn, F, Maranzano, E, Molassiotis, A & Dennis, K 2024, '2023 Updated MASCC/ESMO Consensus Recommendations : prevention of radiotherapy- and chemoradiotherapy-induced nausea

Record details

×
Academic Journal

2023 Updated MASCC/ESMO Consensus Recommendations:prevention of radiotherapy- and chemoradiotherapy-induced nausea and vomiting

Subjects: Antiemetic; Concomitant chemotherapy; Guideline

  • Source: Ruhlmann, C H, Jordan, K, Jahn, F, Maranzano, E, Molassiotis, A & Dennis, K 2024, '2023 Updated MASCC/ESMO Consensus Recommendations : prevention of radiotherapy- and chemoradiotherapy-induced nausea

Record details

×
Academic Journal

Minimal important difference in postoperative morphine consumption after hip and knee arthroplasty using nausea, vomiting, sedation and dizziness as anchors

Subjects: anchor-based methods; minimal important difference; morphine

  • Source: Karlsen, A P H, Laigaard, J, Pedersen, C, Thybo, K H, Gasbjerg, K S, Geisler, A, Lunn, T H, Hägi-Pedersen, D, Jakobsen, J C & Mathiesen, O 2024, 'Minimal important difference in postoperative

Record details

×
Academic Journal

Minimal important difference in postoperative morphine consumption after hip and knee arthroplasty using nausea, vomiting, sedation and dizziness as anchors

Subjects: anchor-based methods; minimal important difference; morphine

  • Source: Karlsen, A P H, Laigaard, J, Pedersen, C, Thybo, K H, Gasbjerg, K S, Geisler, A, Lunn, T H, Hägi-Pedersen, D, Jakobsen, J C & Mathiesen, O 2024, 'Minimal important difference in postoperative

Record details

×
Academic Journal

Neurokinin-1 receptor antagonists:review of their role for the prevention of chemotherapy-induced nausea and vomiting in adults

Subjects: adherence; antiemetics; Chemotherapy-induced nausea and vomiting (CINV)

  • Source: Karthaus, M, Schiel, X, Ruhlmann, C H & Celio, L 2019, 'Neurokinin-1 receptor antagonists : review of their role for the prevention of chemotherapy-induced nausea and

Record details

×
Academic Journal

Neurokinin-1 receptor antagonists:review of their role for the prevention of chemotherapy-induced nausea and vomiting in adults

Subjects: adherence; antiemetics; Chemotherapy-induced nausea and vomiting (CINV)

  • Source: Karthaus, M, Schiel, X, Ruhlmann, C H & Celio, L 2019, 'Neurokinin-1 receptor antagonists : review of their role for the prevention of chemotherapy-induced nausea and

Record details

×
Academic Journal

Safety and antiemetic efficacy of weekly administration of netupitant/palonosetron plus dexamethasone during 5 weeks of concomitant chemo-radiotherapy—the DANGER-emesis study

Subjects: Concomitant chemoradiotherapy; Nausea; NEPA

  • Source: Detlefsen, S S, Andersen, D S, Knudsen, A, Nøttrup, T J, Möller, S, Nyvang, G B, Jørgensen, T L, Herrstedt, J & Ruhlmann, C H 2025, 'Safety and antiemetic efficacy of weekly administration of

Record details

×
Academic Journal

Safety and antiemetic efficacy of weekly administration of netupitant/palonosetron plus dexamethasone during 5 weeks of concomitant chemo-radiotherapy—the DANGER-emesis study

Subjects: Concomitant chemoradiotherapy; Nausea; NEPA

  • Source: Detlefsen, S S, Andersen, D S, Knudsen, A, Nøttrup, T J, Möller, S, Nyvang, G B, Jørgensen, T L, Herrstedt, J & Ruhlmann, C H 2025, 'Safety and antiemetic efficacy of weekly administration of

Record details

×
  • 1-10 of  121 results for ""Vomiting""